<?xml version="1.0" encoding="UTF-8"?>
<record
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd"
    xmlns="http://www.loc.gov/MARC21/slim">

  <leader>04642cam a2200397 a 4500</leader>
  <controlfield tag="001">3387298</controlfield>
  <controlfield tag="003">BD-DhUL</controlfield>
  <controlfield tag="005">20150121171945.0</controlfield>
  <controlfield tag="008">010921s2002    paua     b    001 0 eng  </controlfield>
  <datafield tag="010" ind1=" " ind2=" ">
    <subfield code="a">  2001050327</subfield>
  </datafield>
  <datafield tag="020" ind1=" " ind2=" ">
    <subfield code="a">0683307371</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
    <subfield code="a">(OCoLC)48057043</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
    <subfield code="a">(OCoLC)ocm48057043</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
    <subfield code="a">(NNC)3387298</subfield>
  </datafield>
  <datafield tag="040" ind1=" " ind2=" ">
    <subfield code="a">BD-DhUL</subfield>
    <subfield code="c">BD-DhUL</subfield>
    <subfield code="d">OrLoB-B</subfield>
  </datafield>
  <datafield tag="050" ind1="0" ind2="0">
    <subfield code="a">RS403</subfield>
    <subfield code="b">.P75 2002</subfield>
  </datafield>
  <datafield tag="082" ind1="0" ind2="0">
    <subfield code="a">615.19</subfield>
    <subfield code="b">WIF</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
    <subfield code="a">Foye's principles of medicinal chemistry /</subfield>
    <subfield code="c">[edited by] David A. Williams, Thomas L. Lemke.</subfield>
  </datafield>
  <datafield tag="246" ind1="3" ind2="0">
    <subfield code="a">Principles of medicinal chemistry</subfield>
  </datafield>
  <datafield tag="250" ind1=" " ind2=" ">
    <subfield code="a">5th ed.</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="a">Philadelphia :</subfield>
    <subfield code="b">Lippincott Williams &amp; Wilkins,</subfield>
    <subfield code="c">c2002.</subfield>
  </datafield>
  <datafield tag="300" ind1=" " ind2=" ">
    <subfield code="a">xii, 1114 p. :</subfield>
    <subfield code="b">ill. ;</subfield>
    <subfield code="c">29 cm.</subfield>
  </datafield>
  <datafield tag="365" ind1=" " ind2=" ">
    <subfield code="a">IRS</subfield>
    <subfield code="b">1500.00</subfield>
  </datafield>
  <datafield tag="504" ind1=" " ind2=" ">
    <subfield code="a">Includes bibliographical references and indexes.</subfield>
  </datafield>
  <datafield tag="505" ind1="0" ind2="0">
    <subfield code="t">Introduction: Origins of Medicinal Chemistry /</subfield>
    <subfield code="r">William O. Foye --</subfield>
    <subfield code="g">Pt. I.</subfield>
    <subfield code="t">Principles of Drug Discovery --</subfield>
    <subfield code="t">Overview: Drug Design and Development: A Perspective /</subfield>
    <subfield code="r">Michael Williams.</subfield>
    <subfield code="g">1.</subfield>
    <subfield code="t">Natural Products /</subfield>
    <subfield code="r">Alice M. Clark.</subfield>
    <subfield code="g">2.</subfield>
    <subfield code="t">Drug Design and Relationship of Functional Groups to Pharmacologic Activity /</subfield>
    <subfield code="r">James J. Knittel and Robin M. Zavod.</subfield>
    <subfield code="g">3.</subfield>
    <subfield code="t">Molecular Modeling and Drug Design /</subfield>
    <subfield code="r">Eric Billings.</subfield>
    <subfield code="g">4.</subfield>
    <subfield code="t">Receptors and Drug Action /</subfield>
    <subfield code="r">Timothy J. Maher and David A. Johnson.</subfield>
    <subfield code="g">5.</subfield>
    <subfield code="t">Drug Design Through Enzyme Inhibition /</subfield>
    <subfield code="r">Stephen G. Kerr.</subfield>
    <subfield code="g">6.</subfield>
    <subfield code="t">Peptide and Protein Drugs /</subfield>
    <subfield code="r">Michael Mokotoff.</subfield>
    <subfield code="g">7.</subfield>
    <subfield code="t">Physicochemical and Biopharmaceutical Properties of Drug Substances and Pharmacokinetics /</subfield>
    <subfield code="r">Sunil Jambhekar.</subfield>
    <subfield code="g">8.</subfield>
    <subfield code="t">Drug Metabolism /</subfield>
    <subfield code="r">David A. Williams.</subfield>
    <subfield code="g">9.</subfield>
    <subfield code="t">U.S. Drug Regulation: An Overview /</subfield>
    <subfield code="r">Douglas J. Pisano --</subfield>
    <subfield code="g">Pt. II.</subfield>
    <subfield code="t">Pharmacodynamic Agents --</subfield>
    <subfield code="t">Overview: Drug Receptors: A Perspective /</subfield>
    <subfield code="r">David J. Triggle.</subfield>
    <subfield code="g">10.</subfield>
    <subfield code="t">Drugs Affecting Cholinergic Neurotransmission /</subfield>
    <subfield code="r">Danny L. Lattin and E. Kim Fifer.</subfield>
  </datafield>
  <datafield tag="505" ind1="8" ind2="0">
    <subfield code="g">11.</subfield>
    <subfield code="t">Drugs Affecting Adrenergic Neurotransmission /</subfield>
    <subfield code="r">Robert Griffith.</subfield>
    <subfield code="g">12.</subfield>
    <subfield code="t">Serotonin Receptors and Drugs Affecting Serotonergic Neurotransmission /</subfield>
    <subfield code="r">Richard A. Glennon and Malgorzata Dukat.</subfield>
    <subfield code="g">13.</subfield>
    <subfield code="t">Local Anesthetics /</subfield>
    <subfield code="r">Matthias C. Lu.</subfield>
    <subfield code="g">14.</subfield>
    <subfield code="t">Volatile Anesthetics /</subfield>
    <subfield code="r">Timothy J. Maher.</subfield>
    <subfield code="g">15.</subfield>
    <subfield code="t">Hypnotics /</subfield>
    <subfield code="r">William Soine.</subfield>
    <subfield code="g">16.</subfield>
    <subfield code="t">Antiseizure Drugs /</subfield>
    <subfield code="r">Barbara W. Leduc.</subfield>
    <subfield code="g">17.</subfield>
    <subfield code="t">Psychotherapeutic Drugs: Antipsychotic and Anxiolytic Agents /</subfield>
    <subfield code="r">Raymond G. Booth and John L. Neumeyer.</subfield>
    <subfield code="g">18.</subfield>
    <subfield code="t">Hallucinogens, Stimulants, and Related Drugs of Abuse /</subfield>
    <subfield code="r">Richard A. Glennon.</subfield>
    <subfield code="g">19.</subfield>
    <subfield code="t">Opioid Analgesics /</subfield>
    <subfield code="r">David S. Fries.</subfield>
    <subfield code="g">20.</subfield>
    <subfield code="t">Drugs Used to Treat Neuromuscular Disorders: Antiparkinsonian and Spasmolytic Agents /</subfield>
    <subfield code="r">Raymond G. Booth and John L. Neumeyer.</subfield>
    <subfield code="g">21.</subfield>
    <subfield code="t">Cardiac Agents: Cardiac Glycosides, Antianginal, and Antiarrhythmic Drugs /</subfield>
    <subfield code="r">Ahmed S. Mehanna.</subfield>
    <subfield code="g">22.</subfield>
    <subfield code="t">Diuretics /</subfield>
    <subfield code="r">Gary O. Rankin.</subfield>
    <subfield code="g">23.</subfield>
    <subfield code="t">Angiotensin Converting Enzyme Inhibitors, Antagonists and Calcium Blockers /</subfield>
    <subfield code="r">Marc W. Harrold.</subfield>
  </datafield>
  <datafield tag="505" ind1="8" ind2="0">
    <subfield code="g">24.</subfield>
    <subfield code="t">Central and Peripheral Sympatholytics and Vasodilators /</subfield>
    <subfield code="r">David A. Williams.</subfield>
    <subfield code="g">25.</subfield>
    <subfield code="t">Antihyperlipoproteinemics and Inhibitors of Cholesterol Biosynthesis /</subfield>
    <subfield code="r">Marc W. Harrold.</subfield>
    <subfield code="g">26.</subfield>
    <subfield code="t">Antithrombotics, Thrombolytics, Coagulants and Plasma Extenders /</subfield>
    <subfield code="r">Robert B. Palmer.</subfield>
    <subfield code="g">27.</subfield>
    <subfield code="t">Insulin and Oral Hypoglycemic Drugs /</subfield>
    <subfield code="r">Robert A. Wiley.</subfield>
    <subfield code="g">28.</subfield>
    <subfield code="t">Adrenocorticoids /</subfield>
    <subfield code="r">Duane D. Miller, Robert W. Brueggemeier and James T. Dalton.</subfield>
    <subfield code="g">29.</subfield>
    <subfield code="t">Estrogen, Progestins and Androgens /</subfield>
    <subfield code="r">Robert W. Brueggemeier, Duane D. Miller and James T. Dalton.</subfield>
    <subfield code="g">30.</subfield>
    <subfield code="t">Thyroid Function and Thyroid Drugs /</subfield>
    <subfield code="r">Ali R. Banijamali.</subfield>
    <subfield code="g">31.</subfield>
    <subfield code="t">Calcium Homeostasis /</subfield>
    <subfield code="r">Robin M. Zavod.</subfield>
    <subfield code="g">32.</subfield>
    <subfield code="t">Nonsteroidal Anti-Inflammatory Agents /</subfield>
    <subfield code="r">Ronald F. Borne.</subfield>
    <subfield code="g">33.</subfield>
    <subfield code="t">Antihistamines and Related Antiallergic and Antiulcer Agents /</subfield>
    <subfield code="r">Wendel L. Nelson.</subfield>
    <subfield code="g">34.</subfield>
    <subfield code="t">Antibiotics and Antimicrobial Agents /</subfield>
    <subfield code="r">Lester A. Mitscher.</subfield>
    <subfield code="g">35.</subfield>
    <subfield code="t">Antiparasitic Agents /</subfield>
    <subfield code="r">Thomas L. Lemke.</subfield>
    <subfield code="g">36.</subfield>
    <subfield code="t">Antifungal Drugs /</subfield>
    <subfield code="r">Robert Griffith and Timothy Tracy.</subfield>
    <subfield code="g">37.</subfield>
    <subfield code="t">Antimycobacterial Agents /</subfield>
    <subfield code="r">Thomas L. Lemke.</subfield>
  </datafield>
  <datafield tag="505" ind1="8" ind2="0">
    <subfield code="g">38.</subfield>
    <subfield code="t">Cancer and Cancer Chemotherapy /</subfield>
    <subfield code="r">Patrick S. Callery and Peter M. Gannett.</subfield>
    <subfield code="g">39.</subfield>
    <subfield code="t">Antiviral Agents and Protease Inhibitors /</subfield>
    <subfield code="r">Manohar L. Sethi --</subfield>
    <subfield code="g">Pt. III.</subfield>
    <subfield code="t">Recent Advances in Drug Discovery.</subfield>
    <subfield code="g">40.</subfield>
    <subfield code="t">Pharmaceutical Biotechnology /</subfield>
    <subfield code="r">Robert D. Sindelar.</subfield>
    <subfield code="g">41.</subfield>
    <subfield code="t">Gene Therapy /</subfield>
    <subfield code="r">Ronald E. Reid.</subfield>
    <subfield code="g">42.</subfield>
    <subfield code="t">Antisense Therapeutic Agents /</subfield>
    <subfield code="r">Marilyn K. Speedie.</subfield>
    <subfield code="g">43.</subfield>
    <subfield code="t">Selective Estrogen Receptor Modulators /</subfield>
    <subfield code="r">V. Craig Jordan --</subfield>
    <subfield code="t">pKa Values for Some Drugs and Miscellaneous Organic Acids and Bases; pH Values for Tissue Fluids /</subfield>
    <subfield code="r">David A. Williams.</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="0">
    <subfield code="a">Pharmaceutical chemistry.</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="2">
    <subfield code="a">Chemistry, Pharmaceutical.</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
    <subfield code="a">Lemke, Thomas L.</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
    <subfield code="a">Williams, David A.,</subfield>
    <subfield code="d">1938-</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
    <subfield code="a">Foye, William O.</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2=" ">
    <subfield code="a">AUTH</subfield>
    <subfield code="b">TOC</subfield>
  </datafield>
  <datafield tag="942" ind1=" " ind2=" ">
    <subfield code="2">ddc</subfield>
    <subfield code="c">BK</subfield>
  </datafield>
  <datafield tag="999" ind1=" " ind2=" ">
    <subfield code="c">34798</subfield>
    <subfield code="d">34798</subfield>
  </datafield>
  <datafield tag="952" ind1=" " ind2=" ">
    <subfield code="0">0</subfield>
    <subfield code="1">0</subfield>
    <subfield code="2">ddc</subfield>
    <subfield code="4">0</subfield>
    <subfield code="6">615_190000000000000_WIF</subfield>
    <subfield code="7">0</subfield>
    <subfield code="8">NFIC</subfield>
    <subfield code="9">64778</subfield>
    <subfield code="a">DUSL</subfield>
    <subfield code="b">DUSL</subfield>
    <subfield code="c">GEN</subfield>
    <subfield code="d">2005-07-13</subfield>
    <subfield code="e">Purchased</subfield>
    <subfield code="o">615.19 WIF</subfield>
    <subfield code="p">412604</subfield>
    <subfield code="r">2015-01-21</subfield>
    <subfield code="t">2</subfield>
    <subfield code="w">2015-01-21</subfield>
    <subfield code="y">BK</subfield>
  </datafield>
  <datafield tag="952" ind1=" " ind2=" ">
    <subfield code="0">0</subfield>
    <subfield code="1">0</subfield>
    <subfield code="2">ddc</subfield>
    <subfield code="4">0</subfield>
    <subfield code="6">615_190000000000000_WIF</subfield>
    <subfield code="7">0</subfield>
    <subfield code="8">NFIC</subfield>
    <subfield code="9">64779</subfield>
    <subfield code="a">DUSL</subfield>
    <subfield code="b">DUSL</subfield>
    <subfield code="c">GEN</subfield>
    <subfield code="d">2005-07-13</subfield>
    <subfield code="e">Purchased</subfield>
    <subfield code="o">615.19 WIF</subfield>
    <subfield code="p">412603</subfield>
    <subfield code="r">2015-01-21</subfield>
    <subfield code="t">1</subfield>
    <subfield code="w">2015-01-21</subfield>
    <subfield code="y">BK</subfield>
  </datafield>
</record>
